Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Apixaban (Primary) ; Warfarin
- Indications Atrial fibrillation
- Focus Adverse reactions
- 13 Jul 2017 Trial design published in the Clinical Cardiology
- 27 Apr 2017 Status changed from active, no longer recruiting to completed.
- 10 Mar 2017 Planned End Date changed from 1 Oct 2016 to 5 Apr 2017.